Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Metformin associates with improved myocardial perfusion reserve and survival in patients with Type 2 Diabetes Mellitus

View ORCID ProfileNoor Sharrack, View ORCID ProfileKristopher D Knott, View ORCID ProfileGaurav S Gulsin, View ORCID ProfileTushar Kotecha, View ORCID ProfileLouise AE Brown, View ORCID ProfileJian L Yeo, View ORCID ProfileAldostefano Porcari, View ORCID ProfileRobert D Adam, View ORCID ProfileSharmaine Thirunavukarasu, Amrit Chowdhary, View ORCID ProfileEylem Levelt, View ORCID ProfileJames C Moon, Gerry P McCann, View ORCID ProfileMarianna Fontana, View ORCID ProfilePeter Kellman, Theresa Munyombwe, View ORCID ProfileChristopher Gale, David L Buckley, View ORCID ProfileJohn P Greenwood, View ORCID ProfilePeter P Swoboda, Sven Plein
doi: https://doi.org/10.1101/2023.04.13.23288441
Noor Sharrack
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noor Sharrack
Kristopher D Knott
2Barts Heart Centre, St Bartholomew’s Hospital, London, United Kingdom
3University College London (UCL) Institute of Cardiovascular Science, London, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristopher D Knott
Gaurav S Gulsin
4Department of Cardiovascular Sciences, University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gaurav S Gulsin
Tushar Kotecha
3University College London (UCL) Institute of Cardiovascular Science, London, United Kingdom
5National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London, London, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tushar Kotecha
Louise AE Brown
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise AE Brown
Jian L Yeo
4Department of Cardiovascular Sciences, University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jian L Yeo
Aldostefano Porcari
5National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London, London, United Kingdom
6Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aldostefano Porcari
Robert D Adam
2Barts Heart Centre, St Bartholomew’s Hospital, London, United Kingdom
3University College London (UCL) Institute of Cardiovascular Science, London, United Kingdom
7Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert D Adam
Sharmaine Thirunavukarasu
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
MBChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sharmaine Thirunavukarasu
Amrit Chowdhary
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eylem Levelt
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
MBBS DPhil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eylem Levelt
James C Moon
2Barts Heart Centre, St Bartholomew’s Hospital, London, United Kingdom
3University College London (UCL) Institute of Cardiovascular Science, London, United Kingdom
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James C Moon
Gerry P McCann
4Department of Cardiovascular Sciences, University of Leicester and the NIHR Leicester Cardiovascular Biomedical Research Centre, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianna Fontana
3University College London (UCL) Institute of Cardiovascular Science, London, United Kingdom
5National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London, London, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marianna Fontana
Peter Kellman
8National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter Kellman
Theresa Munyombwe
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
9Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Gale
9Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
10Leeds Institute for Data Analytics, University of Leeds, Leeds, United Kingdom
11Department of Cardiology, Leeds Teaching Hosptislas NHS Trust, Leeds, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher Gale
David L Buckley
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P Greenwood
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John P Greenwood
Peter P Swoboda
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter P Swoboda
Sven Plein
1Biomedical Imaging Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.plein@leeds.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Metformin is an antihyperglycemic agent frequently used in the treatment of Type 2 Diabetes Mellitus (T2DM). Patients with T2DM are at increased risk of cardiovascular diseases, including coronary artery disease (CAD), silent myocardial infarction (MI) and coronary microvascular dysfunction (CMD), all of which can be detected and quantified using Cardiovascular Magnetic Resonance (CMR). We explored the association between metformin use, stress Myocardial Blood Flow (MBF), Myocardial Perfusion Reserve (MPR), survival and major adverse cardiovascular and cerbrovasular events (MACCE; a composite of all-cause death, MI, stroke, heart failure hospitalisation and coronary revascularisation) in patients with T2DM.

Methods A multi-centre study of patients with T2DM, and a cohort of healthy controls underwent quantitative myocardial perfusion CMR. Global MBF and MPR were derived using an automatic artificial intelligence-supported process. Multivariable regression analysis and cox proportional hazard models quantified associations between metformin use, MBF, MPR, all-cause death and MACCE.

Results Analysis included 572 patients with T2DM (68% prescribed metformin) with median follow-up 851 days (interquartile range 935-765). Metformin use was associated with an increase in MPR of 0.12 [0.08-0.40], P=0.004. There was a total of 82 (14.3%) first MACCE in all T2DM patients including a total of 25 (4.4%) deaths. Although the number of first MACCE events was similar for patients prescribed metformin (53 (14%)) compared to those who were not (29 (15.8%) (P=0.73)), there was a total of 9 deaths (2.3%) in patients prescribed metformin compred to 16 (8.7%) in patients who were not, adjusted hazard ratio 0.29 [95% CI 0.12-0.73] P=0.009).

Conclusion In patients with T2DM, metformin use is associated with higher MPR and improved survival.

Clinical Perspective Patients with Type 2 Diabetes Mellitus (T2DM) are at increased risk of cardiovascular disease. Cardiovascular Magnetic Resonane (CMR) can be used to detect and quantify absolute stress myocardial blood flow (MBF) and myocardial perfusion reserve (MPR), both of which are objective measures of coronary microvascular function. Metformin is frequently used in the treatment of T2DM. We investigated the association between metformin use, CMR-derived stress MBF, MPR and clinical outcomes in patients with T2DM.

In a longitudinal cohort study of patients with T2DM, metformin use was associated with higher MPR as a marker of microvascular function, and improved survival after adjusting for certain confounding parameters.

Further prospective studies are needed to confirm the association between metformin use and improved MPR and reduced mortality, as well as to clarify the mechanisms responsible and quantify the dose these associated outcomes are observed.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported directly and indirectly from the National Institute for Health Research Biomedical Research Centres at University College London Hospitals and Barts Health National Health Service Trusts. Recruitment in Leicester was funded through BHF Clinical Research Training Fellowship (G. Gulsin; FS/16/47/32190) and a NIHR Research Professorship (G. McCann; RP-2017-08-ST2-007). Leeds studies were funded by British Heart Foundation with ethical approval from 17/YH/0300, 18/YH/0168 and 18/YH/01900. This research is supported by the National Institute for Health Research (NIHR), through the Local Clinical Research Networks and the NIHR Leeds and Leiciester Clinical Research Facilities. SP is supported by a British Heart Foundation Chair (CH/16/2/32089). EL acknowledges support from the Welcome Trust (221690/Z/20/Z). RDA received funding from the Romanian Society of Cardiology (Research Grant No. 95/01.09.2020).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All the patients provided written informed consent for their inclusion and approval was provided by the respective ethics committees from each site as described below and conducted in accordance with the Declaration of Helsinki. Leeds data was obtained with ethical approval obtained by Leeds Research Ethics Committee (REC), Leeds, United Kingdom, reference 17/YH/0300, 18/YH/0168 and 18/YH/01900. Barts data used ethical approval from East of England, Cambridge Central Research Ethics Committee, United Kingdom, REC 14/EE/0007. Royal Free data was provided by the University College London/University College London Hospital Joint Committees on the Ethics of Human Research for recruitment at Royal Free Hospital (REC reference 07/H0715/101), United Kingdom. Leicester data ethical approval was provided by the UK Health Research Authority Research Ethics Committee (reference 17/WM/0192).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • A multicentre study from the United Kingdom shows that in patients with Type 2 Diabetes Mellitus, metformin associates with improved myocardial perfusion reserve (MPR) and survival.

Data Availability

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

  • Abbreviations

    CAD
    Coronary Artery Disease
    CMD
    Coronary Microvascular Dysfunction
    CMR
    Cardiovascular Magnetic Resonance
    T2DM
    Type 2 Diabetes Mellitus
    LV
    Left Ventricle
    LVEF
    Left Ventricular Ejection Fraction
    MI
    Myocardial Infarction
    MACCE
    Major Adverse Cardiovascular and Cerebrovascular Events
    MBF
    Myocardial Blood Flow
    MPR
    Myocardial Perfusion Reserve
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 17, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Metformin associates with improved myocardial perfusion reserve and survival in patients with Type 2 Diabetes Mellitus
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Metformin associates with improved myocardial perfusion reserve and survival in patients with Type 2 Diabetes Mellitus
    Noor Sharrack, Kristopher D Knott, Gaurav S Gulsin, Tushar Kotecha, Louise AE Brown, Jian L Yeo, Aldostefano Porcari, Robert D Adam, Sharmaine Thirunavukarasu, Amrit Chowdhary, Eylem Levelt, James C Moon, Gerry P McCann, Marianna Fontana, Peter Kellman, Theresa Munyombwe, Christopher Gale, David L Buckley, John P Greenwood, Peter P Swoboda, Sven Plein
    medRxiv 2023.04.13.23288441; doi: https://doi.org/10.1101/2023.04.13.23288441
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Metformin associates with improved myocardial perfusion reserve and survival in patients with Type 2 Diabetes Mellitus
    Noor Sharrack, Kristopher D Knott, Gaurav S Gulsin, Tushar Kotecha, Louise AE Brown, Jian L Yeo, Aldostefano Porcari, Robert D Adam, Sharmaine Thirunavukarasu, Amrit Chowdhary, Eylem Levelt, James C Moon, Gerry P McCann, Marianna Fontana, Peter Kellman, Theresa Munyombwe, Christopher Gale, David L Buckley, John P Greenwood, Peter P Swoboda, Sven Plein
    medRxiv 2023.04.13.23288441; doi: https://doi.org/10.1101/2023.04.13.23288441

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
    Subject Areas
    All Articles
    • Addiction Medicine (280)
    • Allergy and Immunology (577)
    • Anesthesia (139)
    • Cardiovascular Medicine (1942)
    • Dentistry and Oral Medicine (252)
    • Dermatology (183)
    • Emergency Medicine (331)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
    • Epidemiology (11086)
    • Forensic Medicine (8)
    • Gastroenterology (619)
    • Genetic and Genomic Medicine (3156)
    • Geriatric Medicine (307)
    • Health Economics (560)
    • Health Informatics (2037)
    • Health Policy (861)
    • Health Systems and Quality Improvement (781)
    • Hematology (309)
    • HIV/AIDS (682)
    • Infectious Diseases (except HIV/AIDS) (12702)
    • Intensive Care and Critical Care Medicine (707)
    • Medical Education (317)
    • Medical Ethics (92)
    • Nephrology (334)
    • Neurology (2977)
    • Nursing (162)
    • Nutrition (461)
    • Obstetrics and Gynecology (589)
    • Occupational and Environmental Health (614)
    • Oncology (1548)
    • Ophthalmology (474)
    • Orthopedics (185)
    • Otolaryngology (265)
    • Pain Medicine (201)
    • Palliative Medicine (57)
    • Pathology (402)
    • Pediatrics (909)
    • Pharmacology and Therapeutics (381)
    • Primary Care Research (354)
    • Psychiatry and Clinical Psychology (2774)
    • Public and Global Health (5583)
    • Radiology and Imaging (1090)
    • Rehabilitation Medicine and Physical Therapy (630)
    • Respiratory Medicine (755)
    • Rheumatology (338)
    • Sexual and Reproductive Health (311)
    • Sports Medicine (287)
    • Surgery (342)
    • Toxicology (48)
    • Transplantation (159)
    • Urology (131)